Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Cystic fibrosis should be added to diseases sought in all newborn babies
| The first 150 words of the full text of this article appear below. |
EDITOR
Wald and Morris's editorial on neonatal screening for cystic
fibrosis is a good example of the different viewpoints held by doctors
concerned with public health and by clinicians and highlights the need
for both groups to have input into health service policy.1
They reviewed papers describing nutritional benefits of neonatal
diagnosis of cystic fibrosis
2 3
with extrapolations
predicting long term individual health benefits and short to medium
term costs of a screening programme. The differences between screened
and unscreened patients were small in terms of growth during the first
10 years. Healthcare purchasers are more easily persuaded by short term
financial arguments than by long term predictions, particularly when
the predictions involve many uncertainties, but clinicians can advance
other persuasive arguments in favour of screening newborn
babies.
Firstly, for parents to be confronted with the diagnosis of cystic
fibrosis in their baby is always unpleasant. The shock can be mitigated